Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2

PLoS Pathogens(2021)10.1371/journal.ppat.1009599Source: DataRank Database

TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2 is a research paper published in PLoS Pathogens (2021). On theSindex it has a DataRank of 0. It has been cited 63 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access63 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 3.16)OA: goldTopics (65)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Brook E. Heaton ORCID,Ryan R. Chaparian ORCID,Kaitlyn N. Burke ORCID,Raquel A. Binder ORCID,Gregory C. Gray ORCID

Live enrichment

PubMed:34043740 OpenAlex:https://openalex.org/W3165843194

Defense Advanced Research Projects Agency

Grant: #HR00111920008

National Cancer Institute

Grant: T32-CA009111

National Institutes of Health

Grant: 1UC6AI058607-01

Regional Biocontainment Laboratory (RBL)

National Institutes of Health

Grant: 3T32CA009111-38S1

Viral Oncology Training Grant

NCI NIH HHS

Grant: T32 CA009111

NIAID NIH HHS

Grant: UC6 AI058607

FWCI

3.16

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009599&type=printable

publisherhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009599&type=printable

publisherhttps://dx.plos.org/10.1371/journal.ppat.1009599

journalhttps://doi.org/10.1371/journal.ppat.1009599

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34043740

Fields of Study

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studiesinterferon and immune responses0301 basic medicine03 medical and health sciencesAnimalsAntiviral AgentsCOVID-19Cell LineChlorocebus aethiopsCoronavirus 229E, HumanEndoplasmic ReticulumHost Microbial InteractionsHumansMembrane ProteinsSARS-CoV-2Vero CellsVirus Replication

MeSH Terms

Host Microbial InteractionsCOVID-19SARS-CoV-2AnimalsAntiviral AgentsCell LineChlorocebus aethiopsEndoplasmic ReticulumHumansMembrane ProteinsVero CellsVirus ReplicationCoronavirus 229E, Human

Keywords

BiologyViral replicationCoronavirusVirologyHost factorHost factorsViral life cycleHost (biology)VirusViral entryMembrane curvatureComputational biologyCoronavirus disease 2019 (COVID-19)GeneticsMedicineInfectious disease (medical specialty)Host Microbial InteractionsQH301-705.5SARS-CoV-2COVID-19Membrane ProteinsRC581-607Endoplasmic ReticulumVirus ReplicationAntiviral AgentsCell LineCoronavirus 229E, HumanChlorocebus aethiopsAnimalsHumansImmunologic diseases. AllergyBiology (General)Vero CellsResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being